For following the competition: what moved in each program, several studies read as one move.
- vonicog alfa
- latarcibart
- antihemophilic factor, human recombinant
- + 3 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add von Willebrand Diseases to watchlistEvery Monday by email · turn it off any timePro · free during the beta